Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3732776014 | Product containing only ibritumomab tiuxetan (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3732777017 | Ibritumomab tiuxetan only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
2839571000001116 | Ibritumomab tiuxetan (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
2839581000001119 | Ibritumomab tiuxetan | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ibritumomab tiuxetan | Has active ingredient | Ibritumomab tiuxetan | true | Inferred relationship | Existential restriction modifier | 1 | |
Ibritumomab tiuxetan | Is a | Product containing ibritumomab tiuxetan | true | Inferred relationship | Existential restriction modifier | ||
Ibritumomab tiuxetan | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Ibritumomab tiuxetan | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Ibritumomab tiuxetan | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ibritumomab tiuxetan 3.2mg/2ml kit for radiopharmaceutical preparation | Is a | True | Ibritumomab tiuxetan | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets